Target intelligence / Profile preview

RNA, U6 small nuclear 79, pseudogene (RNU6-79P)

Target
RNU6-79P
Molecular classification
Other (snRNA pseudogene)
01

Overview

RNA, U6 small nuclear 79, pseudogene" (RNU6-79P) is a **processed pseudogene** derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential structural and catalytic RNA component of the major spliceosome, a ribonucleoprotein complex critical for the splicing of pre-mRNA in the nucleus of eukaryotic cells[3][2]. However, RNU6-79P itself does **not produce a functional RNA or protein** and does *not participate in splicing or any known regulatory pathway*. Pseudogenes like RNU6-79P arise by retrotransposition events and do not encode for biologically active molecules[5][1]. There is no evidence that RNU6-79P has a role in disease, is a therapeutic target, or is druggable; its status is that of a genomic marker for retrotransposition dynamics. There are no described disease-associations, mechanisms of action, biomarkers, or pharmacological safety concerns for this pseudogene. **Note:** - RNU6-79P is a pseudogene, not a coding gene, protein, or therapeutic target. - The correct target for biological function and therapeutic utility is U6 small nuclear RNA (snRNA), not this pseudogene. - Its utility is limited to genomics research, especially for studying retrotransposition and pseudogene formation in the human genome[5][1]. - No aliases besides standardized gene symbols are in common use.

Other names
RNU6-79RNU6-79P

Beyond the preview

Go deeper on RNA, U6 small nuclear 79, pseudogene (RNU6-79P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 79, pseudogene (RNU6-79P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call